Catalent lays off more gene therapy workers in Baltimorenews2025-11-10T14:13:30+00:00November 10th, 2025|Endpoints News|
UPS, Cencora to expand their US operations; Evotec divests biosimilar business to Sandoznews2025-11-06T14:36:04+00:00November 6th, 2025|Endpoints News|
Supernus halts delivery of some Parkinson’s pumps over supply constraintsnews2025-11-05T18:05:08+00:00November 5th, 2025|Endpoints News|
Teva CEO says IRA drug price negotiations met expectationsnews2025-11-05T17:52:56+00:00November 5th, 2025|Endpoints News|
As pharma pour billions in US manufacturing, CDMOs see future opportunitiesnews2025-11-04T13:00:34+00:00November 4th, 2025|Endpoints News|
Lilly earmarks $3B for new European obesity pill factory news2025-11-03T17:58:52+00:00November 3rd, 2025|Endpoints News|
AstraZeneca, Lilly, Merck contribute $120M to support manufacturing talent in Virginianews2025-11-03T13:19:48+00:00November 3rd, 2025|Endpoints News|
National Resilience secures $825M in funding; Regeneron details US manufacturing plansnews2025-10-30T15:34:59+00:00October 30th, 2025|Endpoints News|
Lilly budgets $1.2B for GLP-1 pill factory in Puerto Rico news2025-10-29T17:38:18+00:00October 29th, 2025|Endpoints News|
WuXi AppTec to shutter Texas-based clinical research business news2025-10-29T10:31:41+00:00October 29th, 2025|Endpoints News|
